- R&D Pipeline
- Season 2 (2021-2030)
| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Construction of a new paradigm for gallstone treatment | ||||||
| Small Molecules | Cholelithiasis | Gallstone | Candidate | Surginex | RS-2022-00167125 | ||
| 2 | Lead identification for functional dyspepsia and cancer cachexia using small molecule compound targeting ghrelin receptor | ||||||
| Small Molecules | Dyspepsia | Ghrelin receptor | Hit | Kyungpook National University | HN21C0438 | ||